On Friday, Nov. 1, and as discussed in a previous Hot Off the Hill blog post, President Trump nominated Dr. Stephen Hahn, Chief Executive of the MD Anderson Cancer Center, for FDA Commissioner.

HHS Secretary Alex Azar also announced leadership changes to complement the president’s announcement.

This action brings significant executive leadership change into…

Due to federal rules applicable to “acting” agency heads, the current FDA Acting Commissioner, Ned Sharpless, or another person, should be nominated to be FDA Commissioner by month’s end. In order to be named FDA Commissioner, Senate confirmation is required.

This is a critical time for FDA as they face the ongoing fiscal…